APOE and atherosclerosis: Small molecule-mediated inhibition of CD40-TRAF6 also hampered the initiation of atherosclerosis in Apoe-/- mice by reducing inflammatory cell content in the plaques and prevented the progression of established atherosclerosis and induced a stable plaque phenotype [71].